Given (1) the implications of mitochondrial dysfunction and oxidative stress in PD and (2) the critical role of MC-I in maintaining redox homeostasis, targeting MC-I may constitute a promising diagnostic and therapeutic approach in PD. Here, MCIDAS is linked to Parkinson disease.